Medifirst Solutions 10-Q 23 May 16 2016 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2016	May. 23, 2016
Document and Entity Information [Abstract]
Entity Registrant Name	Medifirst Solutions, Inc.
Entity Central Index Key	1,522,704
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Mar. 31, 2016
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q1
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		49,234,167

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Current Assets:
Cash	$ 203,353	$ 156,958
Notes receivable (investor)	93,130
Inventory	50,000	$ 50,000
Total current assets	346,483	206,958
Property, Plant and Equipment, net	1,813	$ 2,159
Other Assets
Intangible Asset -License Agreement, net	148,753
Total other assets	148,753
Total Assets	497,049	$ 209,117
Liabilities
Accounts payable and accrued expenses	85,250	123,648
Accrued expenses - officer's compensation	376,026	370,000
Due to related party	8,921	8,921
Loans payable - stockholders	20,480	$ 24,449
Note Payable for license agreement	150,000
Convertible notes payable	243,713	$ 180,393
Derivative Liabilities	532,693	157,617
Total current liabilities	$ 1,417,083	$ 865,028
Commitments & Contingencies (Note 10)
Stockholders' Equity:
Common stock, $0.0001 par value; 1,500,000,000 shares authorized, 41,588,879 and 35,101,750 shares issued and outstanding, respectively	$ 4,160	$ 3,510
Additional paid in capital	380,021	310,183
Accumulated deficit	(1,304,223)	(969,609)
Total Stockholders' Deficit	(920,034)	(655,911)
Total Liabilities and Stockholders' Deficit	497,049	209,117
Series A preferred stock
Stockholders' Equity:
Preferred stock	5	$ 5
Series B Preferred Stock
Stockholders' Equity:
Preferred stock	$ 3

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2016	Dec. 31, 2015
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	1,500,000,000	1,500,000,000
Common stock, shares issued	41,588,879	35,101,750
Common stock, shares outstanding	41,588,879	35,101,750
Series A preferred stock
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	50,000	50,000
Preferred stock, shares outstanding	50,000	50,000
Series B Preferred Stock
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	50,000	50,000
Preferred stock, shares issued	31,600	0
Preferred stock, shares outstanding	31,600	0
Common stock, shares issued	1,700,000

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Statements of Operations [Abstract]
Consulting fee revenue
Product sales, net
Total Revenues
Cost of goods sold
Gross income
Expenses:
Officer's compensation	$ 25,000	$ 25,000
Advertising and promotion	1,623	1,283
Computer and internet	120	710
Consulting fees	20,798	4,802
Professional fees	$ 24,560	775
Provision for bad debts		$ 2,255
Rent	$ 2,071
Travel	260
Other	9,371	$ 11,734
Total Operating Expenses	83,803	46,559
Net loss from Operations before other income, expenses	(83,803)	(46,559)
Other income and (expenses)
Interest expense	(191,815)	$ (336)
Interest income	1,167
Change in Fair Value -Derivatives	(60,163)
Net loss	$ (334,614)	$ (46,895)
Loss per common share - Basic and fully diluted	$ (0.009)	$ (0.002)
Weighted average number of shares outstanding - Basic and fully diluted	38,705,017	23,290,959

Consolidated Statement of Stock

Consolidated Statement of Stockholders' Equity - USD ($)	Total	Common Stock	Preferred Class A	Preferred Class B	Additional Paid in Capital	Accumulated Deficit
Beginning Balance at Dec. 31, 2014	$ (364,477)	$ 2,248	$ 5		$ 258,755	$ (625,485)
Beginning Balance, Shares at Dec. 31, 2014		22,481,750	50,000
Issuance of common shares upon partial conversion of note at $0.0001 per share	$ 2,000	$ 200			1,800
Issuance of common shares upon partial conversion of note at $0.0001 per share, Shares		2,000,000
Cancellation of common shares		$ (50)			50
Cancellation of common shares, Shares		(500,000)
Issuance of common shares upon partial conversion of note at $0.0005 per share	$ 400	$ 80			320
Issuance of common shares upon partial conversion of note at $0.0005 per share, Shares		800,000
Contribution to additional paid in capital	1,050				1,050
Issuance of common shares upon partial conversion of note at $0.0005 per share	150	$ 30			120
Issuance of common shares upon partial conversion of note at $0.0005 per share, Shares		300,000
Issuance of common shares upon partial conversion of note at $0.0005 per share	500	$ 100			400
Issuance of common shares upon partial conversion of note at $0.0005 per share, Shares		1,000,000
Issuance of common shares upon partial conversion of note at $0.0005 per share	500	$ 100			400
Issuance of common shares upon partial conversion of note at $0.0005 per share, Shares		1,000,000
Contribution to additional paid in capital	1,575				1,575
Issuance of common shares upon partial conversion of note at $0.0005 per share	1,900	$ 380			1,520
Issuance of common shares upon partial conversion of note at $0.0005 per share, Shares		3,800,000
Issuance of common shares to acquire subsidiary at $0.015 per share	20	$ 2			18
Issuance of common shares to acquire subsidiary at $0.015 per share, Shares		20,000
Issuance of common shares for services $0.01 per share	35,000	$ 350			34,650
Issuance of common shares for services $0.01 per share, Shares		3,500,000
Contribution to additional paid in capital	1,575				$ 1,575
Issuance of common shares to investor $0.01 per share	20	$ 20
Issuance of common shares to investor $0.01 per share, Shares		200,000
Issuance of common shares for services $0.01 per share	5,000	$ 50			$ 4,950
Issuance of common shares for services $0.01 per share, Shares		500,000
Additional paid in capital on debt discount related to the intrinsic beneficial conversion feature	3,000				3,000
Net loss	(344,124)					$ (344,124)
Ending Balance at Dec. 31, 2015	(655,911)	$ 3,510	$ 5		310,183	$ (969,609)
Ending Balance, Shares at Dec. 31, 2015		35,101,750	50,000
Issuance of common shares upon partial conversion of note at $0.00275 per share	3,011	$ 110			2,901
Issuance of common shares upon partial conversion of note at $0.00275 per share, Shares		1,095,036
Issuance of common shares upon partial conversion of note at $0.00275 per share	3,535	$ 129			3,406
Issuance of common shares upon partial conversion of note at $0.00275 per share, Shares		1,285,560
Issuance of common shares upon partial conversion of note at $0.003355 per share	3,041	$ 91			2,950
Issuance of common shares upon partial conversion of note at $0.003355 per share, Shares		906,533
Issuance of common shares upon partial conversion of note at $0.00275 per share	750	$ 150			$ 600
Issuance of common shares upon partial conversion of note at $0.00275 per share, Shares		1,500,000
Issuance of Series B Preferred shares as part consideration for license agreement	3			$ 3
Issuance of Series B Preferred shares as part consideration for license agreement, Shares				25,000
Issuance of Series B preferred shares as payment for inventory	50,000			$ 1	$ 49,999
Issuance of Series B preferred shares as payment for inventory, Shares				10,000
Issuance of common shares upon conversion of 3,400 shares of Series B Preferred Stock	(1)	$ 170		$ (1)	(170)
Issuance of common shares upon conversion of 3,400 shares of Series B Preferred Stock, Shares		1,700,000		(3,400)
Additional paid in capital from derivative liability on debt conversion	10,152				10,152
Net loss	(334,614)					$ (334,614)
Ending Balance at Mar. 31, 2016	$ (920,034)	$ 4,160	$ 5	$ 3	$ 380,021	$ (1,304,223)
Ending Balance, Shares at Mar. 31, 2016		41,588,879	50,000	31,600

Consolidated Statement of Stoc6

Consolidated Statement of Stockholders' Equity (Parenthetical) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2016	Dec. 31, 2015
Issuance of common shares upon partial conversion of note, share price		$ 0.0001
Issuance of common shares upon partial conversion of note, share price one		0.0005
Issuance of common shares upon partial conversion of note, share price two		0.0005
Issuance of common shares upon partial conversion of note, share price three		0.0005
Issuance of common shares upon partial conversion of note, share price four		0.0005
Issuance of common shares upon partial conversion of note, share price five		0.0005
Issuance of common shares to acquire subsidiary, share price		0.015
Issuance of common shares upon partial conversion of note, share price six	$ 0.00275
Issuance of common shares upon partial conversion of note, share price seven	0.00275
Issuance of common shares upon partial conversion of note, share price eight	0.003355
Issuance of common shares upon partial conversion of note, share price nine	$ 0.00275
Common Stock
Issuance of common shares for services , share price		0.01
Issuance of common shares to investor, share price		0.01
Issuance of common shares for services, share price one		$ 0.01
Series B Preferred Stock
Issuance of common shares upon conversion of Series B Preferred Stock	3,400

Consolidated Statement of Cash

Consolidated Statement of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Cash flows from operating activities:
Net loss	$ (334,614)	$ (46,895)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation & amortization expense	$ 1,596	416
Provision for doubtful accounts		$ 2,255
Accrued Interest Receivable	$ (1,167)
Prepaid expenses		$ 750
Accounts payable and accrued expenses	$ 17,627	31,278
Interest/excess of fair value of shares issued to repay loans		2,400
Capitalized rent expense		$ 1,050
Notes payable derivatives	$ 211,922
Stockholder's loan	(3,969)	$ 12,514
Net cash used by operating activities	$ (108,605)	$ 3,768
Cash flows from investing activities:
Net cash used by investing activities
Cash flows from financing activities:
Bank overdraft		$ (4,197)
Due to related party		2,984
Proceeds from convertible notes payable	$ 155,000	(125)
Net cash provided by financing activities	155,000	(1,338)
Net increase (decrease) in cash	46,395	$ 2,430
Cash at beginning of period	156,958
Cash at end of period	$ 203,353	$ 2,430
Cash paid during the period for:
Interest		$ 336
Income taxes

Nature of Operations and Summar

Nature of Operations and Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2016
Nature of Operations and Summary of Significant Accounting Policies [Abstract]
NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Note 1. NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization Medifirst Solutions, Inc. ("MSI" or the "Company") was incorporated in Nevada in November 2010. The Company has not generated significant sales to date. The Company intends to have a diverse product line of consumer products. Since inception, the Company has been engaged in business planning activities, including researching the industry, identifying target markets for the Company's products, developing the Company's models and financial forecasts, performing due diligence regarding potential geographic locations most suitable for establishing the Company's offices and identifying future sources of capital. At the present time, the Company is building products and affiliations in and related to the cosmetic healthcare industry. Pursuant to a sale and purchase agreement dated August 19, 2015 between the Company and the Company's president, the Company acquired 100% of the equity interests in Medical Lasers Manufacturer, Inc. ("MLM") with the total purchase price of 20,000 shares of the Company's common stock at $0.001 per share (or $20). The fair value of the acquired entity was $20. The transaction was considered as a business acquisition and accordingly the acquisition method of accounting has been applied. MLM had no assets at the date of the business combination. The Consolidated financial statements include the accounts of MSI and its only wholly owned subsidiary, MLM. All material intercompany balances and transactions have been eliminated in consolidation. The Company’s activities are subject to significant risks and uncertainties, including failing to secure additional funding to operationalize the Company’s current technology. Basis of Presentation The accompanying unaudited financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted pursuant to such principles and regulations of the Securities and Exchange Commission for Form 10-Q. All adjustments, consisting of normal recurring adjustments, have been made which, in the opinion of management, are necessary for a fair presentation of the results of interim periods. The results of operations for such interim periods are not necessarily indicative of the results that may be expected for a full year because of, among other things, seasonality factors in the retail business. The unaudited financial statements contained herein should be read in conjunction with the audited financial statements and notes thereto for the fiscal year ended December 31, 2015. Revenue Recognition In general, the Company records revenue when persuasive evidence of an arrangement exists, services have been rendered or product delivery has occurred, the sales price to the customer is fixed or determinable, and collectability is reasonably assured. The following policies reflect specific criteria for the various revenues streams of the Company: Revenue is recognized at the time the product is delivered or services are performed. Provision for sales returns are estimated based on the Company's historical return experience. Revenue is presented net of returns. Notes receivable (Investor) In January 2016 the company entered into a securities purchase agreement with an investor (as more fully described in Note 5 below). As part of that agreement, the company issued convertible 8% notes payable to the investor in the amounts of $105,000, $50,000, $50,000 and $46,803. Two of these notes will close subsequent to March 31, 2016 and are secured by fully collateralized promissory notes issued by the Investor to the Company in the total amount of $96,803 ($50,000 and $46,803 - also known as the "back-end notes") and are reported in the balance sheet at $93,130 net of legal fees in the amount of $4,840 plus accrued interest of $1,167. These notes bear interest at the rate of 8% per annum. Interest income in the amount of $1,167 has been accrued for the quarter ended March 31, 2016 on these back-end notes. Accounts Receivable The Company extends credit to its customers in the normal course of business and performs ongoing credit evaluations of its customers, maintaining an allowance for potential credit losses. Accounts receivable is reported net of the allowance for doubtful accounts. The allowance is based on management's estimate of the amount of receivables that will actually be collected. Inventory Inventory consists of finished goods and is stated at the lower of cost (first-in, first-out) or market value. Equipment Equipment, consisting of computer equipment, is stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets, of five years. Long-Lived Assets The Company reviews long-lived assets, such as equipment, for impairment whenever events or changes in circumstances indicate the carrying amount may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds the estimated future cash flows, an impairment loss will be recorded by the amount the carrying value exceeds the fair value of the asset. In August 2015, the Company's wholly-owned subsidiary MLM, acquired a trademark for $20,000. Due to the uncertainty of future cash flows from the trademark, management has deemed it to be impaired and recorded an impairment expense of $20,000 in September 2015. Intangible Asset- Licensing Agreement On March 8th 2016, the company, through its sole wholly-owned subsidiary ("Licensee"), entered into a Product and Know-How License Agreement ("Agreement") with a Florida Corporation ("Licensor"). This Florida Corporation is owned by a related party – the son of the Company’s CEO. The license provides with respect to the Technology, Licensor hereby grants to Licensee an irrevocable, nontransferable, royalty-bearing license, with a right of sublicense (the “License”), throughout the Territory in the Field of Use, whether or not under the Licensed Patent, to: ● use or submit or deliver the Technology and/or any Product to any regulatory body throughout the Territory for purposes of obtaining approval to make, Sell, offer for Sale, import, export and distribute the Technology or Products; and ● use or copy the Technology and/or any Product; and ● market, make, have made, Sell, offer for Sale, import and distribute Products; and ● sublicense the Technology as set forth in Article 4 below; and ● prepare, or have prepared on its behalf, modifications, enhancements and/or derivative works of the Technology. In connection with the license granted under Section 2.1 above, Licensor hereby grants to Licensee a license to the Licensed Patents, whether now existing or hereafter acquired. The consideration for the licensing agreement consisted of the issuance of 25,000 Series B Preferred stock shares to the Licensor (at par) plus a $150,000 promissory note issued by the Company to the licensor. The last part of the consideration in this license agreement is the royalty payments which have not taken effect yet as they are based on sales for which the company has none. Both the stock issuance and promissory notes have "claw-back" provisions should certain events fail to occur. The licensing agreement is for a ten year period effective from March 8th 2016. The cost of the licensing agreement is being amortized over its ten-year period and charged to income on a straight-line basis. Debt Issues Costs and Debt Discount The Company may pay debt issue costs, and record debt discounts in connection with raising funds through the issuance of convertible debt. These costs are amortized over the life of the debt to interest expense. If a conversion of the underlying debt occurs, a proportionate share of the unamortized amounts is immediately expensed. For March 31, 2016 and retroactively, the Company has early-adopted ASU 2015-03: Simplifying the Presentation of Debt Issuance Costs and has reflected the deferred financing costs as a direct reduction of the related debt (See Note 7 to Consolidated Financial Statements). Original Issue Discount For certain convertible debt issued, the Company provides the debt holder with an original issue discount. The original issue discount is recorded to debt discount, reducing the face amount of the note and is amortized to interest expense over the life of the debt. Derivative Liabilities Fair value accounting requires bifurcation of embedded derivative instruments such as conversion features in convertible debt or equity instruments, and measurement of their fair value for accounting purposes. The Company assessed its securities for purposes of determining the proper accounting treatment and valuation as set forth in the Statement of Financial Accounting Standard ASC 820–10–35–37 Fair Value in Financial Instruments Accounting for Derivative Instruments and Hedging Activities In assessing the convertible debt instruments, management determines if the convertible debt host instrument is conventional convertible debt and further if there is a beneficial conversion feature requiring measurement. If the instrument is not considered conventional convertible debt, the Company will continue its evaluation process of these instruments as derivative financial instruments. Once the derivative liabilities are determined, they are adjusted to reflect fair value at each reporting period end, with any increase or decrease in the fair value being recorded in results of operations as an adjustment to fair value of derivatives. Use of Estimates The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the condensed consolidated balance sheets and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Financial Instruments The carrying amounts reported in the balance sheets for cash, accounts receivable, accounts payable, and other accrued liabilities approximate their fair values. Segment Information The Company follows Accounting Standards Codification ("ASC") 280, "Segment Reporting". The Company currently operates in a single segment and will evaluate additional segment disclosure requirements as it expands its operations. Net Income (Loss) Per Common Share The Company calculates net income (loss) per share based on the authoritative guidance. Basic earnings (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Diluted earnings (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares and dilutive common stock equivalents outstanding. During periods in which the Company incurs losses, common stock equivalents, if any, are not considered, as their effect would be anti-dilutive. Income Taxes The Company utilizes the accrual method of accounting for income taxes. Under the accrual method, deferred tax assets and liabilities are determined based on the differences between the financial reporting basis and the tax basis of the assets and liabilities, and are measured using enacted tax rates and laws that will be in effect when the differences are expected to reverse. An allowance against deferred tax assets is recognized, when it is more likely than not, that such tax benefits will not be realized. The Company recognizes the financial statement benefit of an uncertain tax position only after considering the probability that a tax authority would sustain the position in an examination. For tax positions meeting a “more-likely-than-not” threshold, the amount recognized in the financial statements is the benefit expected to be realized upon settlement with the tax authority. For tax positions not meeting the threshold, no financial statement benefit is recognized. The Company recognizes interest and penalties, if any, related to uncertain tax positions in income tax expense. The Company did not have any unrecognized tax benefits as of March 31, 2016, and does not expect this to change significantly over the next 12 months. Stock-Based Compensation The Company accounts for equity instruments issued to employees in accordance with ASC 718, Compensation - Stock Compensation. ASC 718 requires all share-based compensation payments to be recognized in the financial statements based on the fair value on the issuance date. Equity instruments granted to non-employees are accounted for in accordance with ASC 505, Equity. The final measurement date for the fair value of equity instruments with performance criteria is the date that each performance commitment for such equity instrument is satisfied or there is a significant disincentive for non-performance. Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At March 31, 2016, the Company had $203,353 in cash equivalents. Recent Pronouncements In May 2014, FASB and IASB issued a new joint revenue recognition standard that supersedes nearly all GAAP guidance on revenue recognition. The core principle of the standard is that revenue recognition should depict the transfer of goods and services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. The new standard is effective for the Company for the fiscal year beginning after December 15, 2017. The Company is currently evaluating the impact of this ASU on the consolidated financial statements. On January 05, 2016, the FASB completed its Classification and Measurement of Financial Instruments project by issuing ASU No. 2016-01, Financial Instruments—Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. The new guidance improves certain aspects of recognition, measurement, presentation and disclosure of financial instruments. For public business entities, the new guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The Company does not believe the impact of its pending adoption of this ASU on the Company’s consolidated financial statements will be material. In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, “Leases” (Topic 842), which requires lessees to recognize the following for all leases (with the exception of short-term leases) at the commencement date: a lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and a right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. The revised guidance must be applied on a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. The revised guidance is effective for the Company beginning in the quarter ending March 31, 2019. The Company is currently evaluating the impact of this ASU on the consolidated financial statements. In April 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-10, “Revenue from Contracts with Customers” (Topic 606), which requires entities to identify performance obligations and recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The ASU also includes implementation guidance on determining whether an entity’s promise to grant a license provides a customer with either a right to use the entity’s intellectual property (which is satisfied at a point in time) or a right to access the entity’s intellectual property (which is satisfied over time). The amendments in this Update affect the guidance in Accounting Standards Update 2014-09, Revenue from Contracts with Customers (Topic 606), which is not yet effective. The effective date and transition requirements for the amendments in this Update are the same as the effective date and transition requirements in Topic 606 (and any other Topic amended by Update 2014-09). Accounting Standards Update 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, defers the effective date of Update 2014-09 by one year. The Company is currently evaluating the impact of this ASU on the consolidated financial statements. The Company acknowledges the recent accounting pronouncements issued during the quarter-ended March 31, 2016 by the FASB in the form of Accounting Standards Updates (“ASUs”) numbered ASU 2016-08, 09, 11 and ASU 2016-12 providing guidance and related to revenue clarifications. The Company believes these pronouncements, when effective, will not have a material impact on the financial statements.

Property, Plant and Equipment (

Property, Plant and Equipment (Net)	3 Months Ended
	Mar. 31, 2016
Property, Plant and Equipment (Net) [Abstract]
PROPERTY, PLANT AND EQUIPMENT (NET)	Note 2. PROPERTY, PLANT AND EQUIPMENT (NET) Equipment is recorded at cost and consisted of the following at March 31, 2016 and December 31, 2015: March 31, 2016 December 31, 2015 Computer equipment $ 8,314 $ 8,314 Less: accumulated depreciation (6,501 ) (6,155 ) $ 1,814 $ 2,159 Depreciation expense was $346 and $416 for the three-month period ended March 31, 2016 and 2015, respectively.

Due to Related Party

Due to Related Party	3 Months Ended
	Mar. 31, 2016
Due to Related Party [Abstract]
DUE TO RELATED PARTY	Note 3. DUE TO RELATED PARTY The Company was indebted to a related party through common management in the amount of $8,921 at March 31, 2016 and December 31, 2015,respectively. The loan bears no interest and is payable on demand.

Loans Payable - Stockholders

Loans Payable - Stockholders	3 Months Ended
	Mar. 31, 2016
Loans Payable - Stockholders/Convertible Notes Payable [Abstract]
LOANS PAYABLE - STOCKHOLDERS	Note 4. LOANS PAYABLE - STOCKHOLDERS During the periods ended March 31, 2016 and 2015 a stockholder of the Company advanced the Company $-0- and $20,670 respectively. The loan has a balance of $10,680 at March 31, 2016. The loan bears no interest and is payable on demand. At March 31, 2016 and March 31, 2015, the Company was indebted to a stockholder in the amount of $1,200 and $4,600, respectively. The loan has an interest rate of 20%. Principal and accrued interest were due and payable on July 2, 2012. In December 2012, the Company issued a promissory note to a stockholder in the amount of $5,000 with interest at 10% per annum. Principal and interest were due and payable on June 2, 2013. In April 2014, the note was amended to provide the note holder with the option to convert the note to the Company's common stock at $0.0001 per share. Subsequently, in 2014, in a private transaction, the note holder transferred $2,500 of note principal to third parties and the new holders converted their holdings into 2,500,000 shares of the Company's common stock. During 2015, the original note holder transferred an additional $2,400 of note principal to third parties who converted their holdings into 2,400,000 shares of the Company's common stock. At March 31, 2016 and March 31, 2015, the loan had balance was $100 and $500, respectively. At March 31, 2016 and March 31, 2015, the Company was indebted to a stockholder in the amount of $1,500 and $1,500, respectively. The loan has an interest rate of 26.7%. Principal and accrued interest were due and payable on January 1, 2014. In February 2016, the Company issued a promissory note to a stockholder in the amount of $7,000 with interest at the rate of 6% per annum. The note matures on February 4th 2017. At March 31, 2016 the full $7,000 note is outstanding.

Convertible Notes Payable

Convertible Notes Payable	3 Months Ended
	Mar. 31, 2016
Loans Payable - Stockholders/Convertible Notes Payable [Abstract]
CONVERTIBLE NOTES PAYABLE	Note 5. CONVERTIBLE NOTES PAYABLE In March 2011, the Company issued $800 aggregate principal amount of 6% convertible notes due in January 2012. Interest on the notes accrue at the rate of 6% per annum and are payable when the notes mature. The notes matured prior to conversion but have not been repaid. Interest continues to accrue at the rate of 6% per annum. The holder of one of the notes converted $110 of note principal into 1,100,000 shares of common stock as follows: Date of Conversion Principal Amount Converted Conversion Rate Shares Received June 2013 $ 70 $ 0.0001 700,000 August 2013 $ 40 $ 0.0001 400,000 In August 2013, in a private transaction, the same note holder transferred $330 of the remaining note principal plus $55 in accrued interest to a third party. In August 2013, in a private transaction, the new note holder transferred $5 of the remaining note principal to a third party who then converted the note into 50,000 shares of common stock. In September 2013, the new note holder converted $100 of note principal into 1,000,000 shares of common stock. In September 2013, in a private transaction, the new note holder transferred $35 of the remaining note principal to a third party who then converted the note into 350,000 shares of common stock. In November and December 2013, the new note holder converted an additional $90 of note principal into 900,000 shares of common stock as follows: Date of Conversion Principal Amount Converted Conversion Rate Shares Received November 2013 $ 40 $ 0.0001 400,000 December 2013 $ 50 $ 0.0001 500,000 In March and April 2014, the new note holder converted an additional $90 of note principal into 900,000 shares of common stock as follows: Date of Conversion Principal Amount Converted Conversion Rate Shares Received March 2014 $ 50 $ 0.0001 500,000 April 2014 $ 40 $ 0.0001 400,000 Subsequent to these conversions there remains $125 in note principal. In July 2013, the holder of the second note converted $240 of note principal into 400,000 shares of the Company's common stock at $0.0006 per share. At December 31, 2015 and 2014, the note had a remaining principal balance of $60 and $60, respectively. At any time on or after the maturity date, the holders of the notes, have the option of converting any of the unpaid principal and interest into the Company's common stock. The notes plus any accrued but unpaid interest are convertible at the rate of $0.0001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock, or 3,506,665 shares at December 31, 2015. In May 2012, the Company issued a $25,000 6% per annum note that matured in November 2012. In December 2012 the note was amended to be a convertible note. Interest on the note accrues interest at 6% per annum and is payable when the note matures. The holder of the $25,000 note had the option of converting it at any time prior to maturity. The note plus any accrued but unpaid interest were convertible at the rate of $0.001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock. The holder of the note converted $1,010 of note principal into 1,010,000 shares of common stock as follows: The holder of the note converted $1,010 of note principal into 1,010,000 shares of common stock as follows: Date of Conversion Principal Amount Converted Conversion Rate Shares Received December 2012 $ 150 $ 0.001 $ 150,000 January 2013 $ 660 $ 0.001 $ 660,000 March 2013 $ 200 $ 0.001 $ 200,000 In July 2013, the Company retired $14,000 of note principal in payment for consulting services provided to the note holder. In July 2013, the note holder converted $300 of note principal into 300,000 shares of the Company's common stock. In July 2013, in a private transaction, the note holder transferred the remaining note principal balance of $9,690 to a third party. In August 2013, in a private transaction, the new note holder transferred $4,475 of principal to a stockholder of the company. In October 2013, the note holder converted $400 of note principal into 400,000 shares of the Company's common stock at $0.001 per share. In October 2014, the note holder converted $1,100 of note principal into 1,100,000 of the Company's common stock. At December 31, 2015, the remaining principal on this portion of the note is $3,715. The note holder has the option of converting the balance at any time with the approval of the Board of Directors. The note plus any accrued but unpaid interest are convertible at the rate of $0.001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock, or 4,154,729 shares at March 31, 2016. In August 2013, the note holder/stockholder converted $700 of note principal into 700,000 shares of the Company's common stock at $0.001 per share. In October 2013, in a private transaction, this note holder transferred $1,000 of note principal to a third party of which $700 was converted into 700,000 shares in June 2014. The remaining principal balance on this portion of the note at March 31, 2016 is $2,075. The note holder has the option of converting the balance at any time with the approval of the Board of Directors. The note plus any accrued but unpaid interest are convertible at the rate of $0.001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock, or 4,154,729 shares at March 31, 2016. In April 2015, the Company issued a $3,000 8% per annum note that matures in October 2015. The holder of the note has the right to convert the principal into shares of the Company's common stock at any time 180 days after the closing date at $0.0001 per share. Interest on the note accrues interest at 8% per annum and is payable when the note matures. In July 2015, the Company issued a convertible note payable in the principal amount of $59,000. The note matures in March 2016 and bears interest at 8%. Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company's common stock at the discounted rate of 55% of the average of the three lowest market trading prices during the 10 days immediately preceding the conversion date. In August 2015, the Company issued a convertible note payable in the principal amount of $38,000. The note matures in March 2016 and bears interest at 8%. Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company's common stock at the discounted rate of 55% of the average of the three lowest market trading prices during the 10 days immediately preceding the conversion date. On October 8, 2015, the Company issued a convertible note payable in the principal amount of $31,000 with an Original Issue Discount of $1,500. The note matures on October 8, 2016 and bears interest at 8%. The note holder has the right at any time to convert any part or all of the outstanding unpaid principal balance into shares of the Company's common stock at the discounted rate of 58% of the lowest market trading price during the 20 days prior to and including the conversion date. In June 2015, the Company issued a convertible note payable in the principal amount of $100,000. The note matures in December 2015 and bears interest at 5%. Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company's common stock at the discounted rate of 50% of the average of the three lowest market trading prices during the 3 days immediately preceding the conversion date. On October 15, 2015 the Company issued a convertible note payable in the principal amount of $35,000 with an Original Issue Discount of $5,000. The note matures on October 15, 2016 and bears interest at 5%. The note holder has the right at any time on or after the day that is six months from October 15, 2015 to convert any part or all of the outstanding unpaid principal balance into shares of the Company's common stock at the discounted rate of 55% of the lowest market trading prices during the 20 days prior to the conversion date. On January 7 2016, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with an accredited investor (the “Investor”) for the sale of convertible redeemable notes in aggregate principal amount of $251,803. On January 7, 2016, the Company and the Investor conducted the first closing under the Purchase Agreement, pursuant to which the Company issued to the Investor (i) a convertible redeemable note in principal amount of $105,000 containing an original issue discount of $20,000 (the “$105K Note”); and (ii) a convertible redeemable note in principal amount of $50,000 (the “$50K Note” and together with the $105K Note, the “Notes”). Under the Purchase Agreement, on March 15, 2016 and June 15, 2016, the Company and the Investor expect to conduct additional closing for the sale and purchase of additional notes having the same terms as the Notes in principal amounts equal to $50,000 and $46, 803, respectively. In consideration for the issuance of the $105K Note, on January 13, 2016, the Company received net proceeds (after deducting the original issue discount and legal fees) in the amount of $75,697. In consideration for the issuance of the $50K Note, the Investor issued to the Company a $50,000 fully-collateralized secured promissory note (the “Investor Note”), pursuant to which the Investor agreed to pay the Company $50,000 on or before April 30, 2016. The Notes, which are due on January 7, 2017, bear interest at the rate of 8% per annum. Subject to a beneficial ownership limitation equal to 9.99%, principal and interest on the Notes is convertible into shares of the Company’s common stock (“Common Stock”) at a conversion price equal to 55% of the lowest trading price of Common Stock during the 20 trading day period prior to conversion. The Company’s convertible notes payable and the related derivative liabilities, derivative discount, deferred financing costs and original-issue discount are presented in the financial statements at March 31, 2016 as follows: Debt Face Amount Original Issue Discount Derivative Discount Deferred Financing Costs Total Convertible Notes Payable Derivative Liability Note Payable - BS $ 125 $ 125 Note Payable - SF 60 60 Note Payable - MC #1 2,075 2,075 Note Payable - NW 3,715 3,715 Note Payable - MC #2 3,000 3,000 Debenture Payable (5%) - B 100,000 100,000 32,293 Convertible Note Payable - LGC (8%) 105,000 (15,397 ) (78,310 ) (7,162 ) 4,130 123,003 Convertible Note Payable - LGC (8%) 50,000 (44,708 ) (1,925 ) 3,367 89,897 Convertible Note Payable - LGC (8%) 50,000 (46,712 ) (2,336 ) 952 88,709 Convertible Note Payable - LGC (8%) 46,803 (43,146 ) (2,186 ) 1,471 83,216 Convertible Note Payable - CB (5%) 35,000 (2,699 ) (540 ) 31,762 Convertible Note Payable - LGC (8%) 31,000 (781 ) (22,861 ) (2,473 ) 4,886 56,366 Convertible Notes Payable- VVtoLG (8%) 49,491 1,358 50,849 59,209 Convertible Notes Payable- VV (8%) #2 38,000 (680 ) 37,320 $ 514,269 $ (18,877 ) $ (234,379 ) $ (17,301 ) $ 243,713 $ 532,693 As of March 31, 2016, the convertible notes payable can be converted into approximately 136,333,000 shares of common stock.

Derivatives and Fair Value Inst

Derivatives and Fair Value Instruments	3 Months Ended
	Mar. 31, 2016
Derivatives and Fair Value Instruments [Abstract]
DERIVATIVES AND FAIR VALUE INSTRUMENTS	Note 6. DERIVATIVES AND FAIR VALUE INSTRUMENTS The Company applied paragraph 815-10-05-4 of the FASB Accounting Standards Codification to the 5% Convertible Notes Payable issued June 12th 2015 and the 8% Convertible Note payable issued June 25th 2015 and also to the 8% convertible notes issued January 7, 2016 and March 7, 2016. Based on the guidance in paragraph 815-10-05-4 of the FASB Accounting Standards Codification the Company concluded these instruments were required to be accounted for as derivatives on issuance date. The Company records the fair value of the Convertible Notes Payable and certain warrants that are classified as derivatives on issuance date and the fair value changes on each reporting date reflected in the consolidated statements of operations as “Gain (loss) on derivative liabilities.” These derivative instruments are not designated as hedging instruments under paragraph 815-10-05-4 of the FASB Accounting Standards Codification and are disclosed on the balance sheet under Derivative Liabilities. The Company follows paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments and paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below: Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2 Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3 Pricing inputs that are generally observable inputs and not corroborated by market data. Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument. The carrying amounts of the Company’s financial assets and liabilities, such as cash, prepayments and other current assets, accounts payable, and accrued expenses, approximate their fair values because of the short maturity of these instruments. The Company’s Level 3 financial liabilities consist of the 5% Convertible Notes Payable issued June 12th 2015 and the 8% Convertible Note payable issued June 25th 2015 and for the 8% Convertible Notes Payable issued January 7, 2016 and March 7, 2016, for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. We have valued the automatic conditional conversion, re-pricing/down-round, change of control; default and follow-on offering provisions using a lattice model, with the assistance of a valuation consultant, for which management understands the methodologies. These models incorporate transaction details such as Company stock price, contractual terms, maturity, risk free rates, as well as assumptions about future financings, volatility, and holder behavior as of issuance and March 31, 2016. The primary assumptions include: projected annual volatility of 151.4%-252%; the follow-on securities purchase option; the conversion feature as a percentage of Market; automatic/conditional conversions; market price trigger events. As of March 31, 2016 the Company’s derivative financial instruments included: 1) Embedded derivatives associated with certain of the Company’s unsecured convertible notes payable. The Company’s 5 % convertible notes payable and 8% convertible notes payable issued to two unrelated investors is a hybrid instrument, which warrants separate accounting as a derivative instrument. The embedded derivative feature has been bifurcated from the debt host contract, referred to as the Derivative Liability, which resulted in a reduction of the initial carrying amount (as unamortized discount) of the Convertible Notes Payable. The unamortized discount is amortized to interest expense using the effective interest method over the life of the Notes. The embedded derivative feature includes the conversion feature within the notes and an early redemption option. The compound embedded derivatives within the convertible notes have been recorded at fair value at the date of issuance; and are marked-to-market each reporting period with changes in fair value recorded to the Company’s statement of operations as Change in fair value of derivative liabilities. The 5% Convertible Note Payable and the 8% Convertible Notes Payable are valued at March 31. 2016. The following assumptions were used for the valuation of the embedded derivative: ● The stock price of $0.010 to $0.0073 in this period (variable conversion price) would fluctuate with the Company projected volatility; ● An event of default for the Convertible Note would occur 0% of the time, increasing 1.00% per month to a maximum of 5.0%; ● Alternative financing for the Convertible Note would be initially available to redeem the note 0% of the time and increase monthly by 1% to a maximum of 10%; ● Capital raising events (a single financing at 1 month from the valuation date) are a factor for the VV to LG Convertible Note. The full reset events projected to occur based on future stock issuance (single event) resulting in a reset exercise price. ● The monthly trading volume would average $211,113 and would increase at 5% per month;ownership limits conversion across LG’s 6 notes based on 4.99% with shares outstanding increasing monthly by 1%. ● The variable conversion price of 50% to 58% over 3 to 20 trading days would have effective rates of 50.55% to 36.13%; ● The Note Holders would automatically convert the notes early (and not hold to maturity) with variable conversion prices and full ratchet resets if the registration was effective and not in default; ● The projected annual volatility for each valuation period was based on the historical volatility of the company: 12/31/2015 151 % 1/7/2016 222 % 1/12/2016 226 % 2/23/2016 234 % 3/7/2016 227 % 3/11/2016 245 % 3/31/2016 252 % The foregoing assumptions are reviewed quarterly and are subject to change based primarily on management’s assessment of the probability of the events described occurring. Accordingly, changes to these assessments could materially affect the valuation. The Company’s convertible notes payable and the related derivative liabilities, derivative discount and original-issue discount are presented in the financial statements at March 31, 2016 as follows: Convertible Note Derivative Treatment Date Maturity Date Principal Note Amount Original Derivative Valuation Derivative Valuation December 31, 2015 Conversions Mark to Market Derivative Valuation March 31, 2016 8% Convertible Note Payable- issued 10/8/2015 10/8/2015 10/8/2015 $ 31,000 $ 58,779 $ 56,366 $ (4,203 ) $ 52,163 5 % Convertible Note- Payable - issued 6/12/2015 12/9/2015 12/12/2015 100,000 37,827 35,176.00 (2,883 ) 32,293 8% Convertible Notes Payable- issued 6/25/2015 12/22/2015 1/7/2017 59,000 56,956 66,075.00 (10,151.00 ) 3,285 59,209 8% Convertible Notes Payable- issued January 7, 2016 1/7/2016 1/7/2017 105,000 87,287 - 39,919 127,206 8% Convertible Notes Payable- issued January 7, 2016 1/7/2016 1/7/2017 50,000 68,124 - 21,773 89,897 8% Convertible Notes Payable- issued March 7, 2016 3/7/2016 3/7/2017 50,000 87,538 - 1,171 88,709 8% Convertible Notes Payable- issued March 7, 2016 3/7/2016 1/7/2017 46,803 82,115 - 1,101 83,216 $ 441,803 $ 478,626 $ 157,617 $ (10,151 ) $ 60,163 $ 532,693

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Mar. 31, 2016
Stockholders' Equity [Abstract]
STOCKHOLDERS' EQUITY	Note 7. STOCKHOLDERS' EQUITY The Company has authorized 1,500,000,000 shares of common stock with a par value of $0.0001 per share. There were 41,588,879 and 35,101,750 shares of common stock issued and outstanding at March 31, 2016 and December 31, 2015, respectively. The Company has authorized 1,000,000 shares of Series A preferred stock with a par value of $0.0001 per share. At March 31, 2016 and December 31, 2015, 50,000 shares of Series A preferred stock were issued and outstanding. The preferred stock has preferential voting rights of 100 votes per outstanding share. The Company has authorized 50,000 shares of Series B convertible preferred stock with a par value of $0.0001 per share. At March 31, 2016 there were 35,000 issued of which 3,400 shares of Series B preferred were converted into common stock in accordance with the terms of the Series B Preferred stock. Therefore; there were 31,400 shares outstanding at March 31, 2016. The Series B preferred stock has no voting rights. The holders of the Series B convertible preferred stock have the right to convert the same into Common Stock of the Corporation at the ratio of one (1) share of Series B Convertible Preferred for five hundred (500) shares of Common Stock. During the quarter ended March 31, 2015, the Company issued 2,000,000 shares of common stock at $0.001 per share as partial conversion of notes. During the quarter ended March 31, 2015, the Company issued 800,000 shares of common stock at $0.0005 per share as partial conversion of notes. During the quarter ended March 31, 2015, a stockholder of the Company returned 500,000 shares of common stock to the Company. During the quarter ended June 30, 2015, the Company issued 2,300,000 shares of common stock at $0.0005 per share as partial conversion of notes. During the quarter ended September 30, 2015, the Company issued 3,800,000 shares of common stock at $0.0005 per share as partial conversion of notes. During the quarter ended September 30, 2015, the Company issued 20,000 shares of common stock at $0.015 per share as to acquire 100% of the outstanding shares of the Company's subsidiary. During the quarter ended September 30, 2015, the Company issued 3,000,000 shares of common stock at $0.01 per share as Officer's compensation. During the quarter ended September 30, 2015, the Company issued 500,000 shares of common stock at $0.01 per share for services provided to the Company. During the quarter ended December 31, 2015, the Company issued 500,000 shares of common stock at $0.01 per share for services provided to the Company. During the quarter ended December 31, 2015, the Company issued 200,000 shares of common stock at $0.01 per share to an investor. During the quarter ended March 31, 2016, the Company issued 1,095,036 shares of common stock at $0.00275 per share as partial conversion of notes. During the quarter ended March 31, 2016, the Company issued 1,285,560 shares of common stock at $0.00275 per share as partial conversion of notes. During the quarter ended March 31, 2016, the Company issued 906,533 shares of common stock at $0.003355 per share as partial conversion of notes. During the quarter ended March 31, 2016, the Company issued 1,500,000 shares of common stock at $0.00275 per share as partial conversion of notes. During the quarter ended March 31, 2016, the Company issued 1,700,000 shares of common stock upon conversion of 3,400 shares of Series B preferred stock. During the quarter ended March 31, 2016, the Company issued 10,000 shares of Series B Preferred stock in settlement of the $50,000 liability to a related party for the purchase of inventory.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2016
Commitments and Contingencies [Abstract]
COMMITMENTS AND CONTINGENCIES	Note 8. COMMITMENTS AND CONTINGENCIES The Company currently rents its offices on a month to month basis from the Company's President and stockholder for $525 per month which amounted to $1,725 for the quarter-ended March 31, 2016. The Company also has ready-to-go office space available to be used for meetings etc. at a nominal cost of approximately $100 per month with no commitment. The cost of this space for the quarter-ended March 31, 2016 was $346. Total rent expense for the quarter ended March 31, 2016 and 2015, totaled $2,071 and $-0-, respectively.

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2016
Income Taxes [Abstract]
INCOME TAXES	Note 9. INCOME TAXES The Company's deferred tax asset consists primarily of carryforward net operating losses (NOLs). The Company believes that, at this time, it is more likely than not that the benefit of the NOLs will not be realized and has therefore recorded a full valuation allowance. The income tax benefit differs from the amount computed by applying the statutory federal and state income tax rates to the loss before income taxes. The sources and tax effects of the differences are as follows: December 31, 2015 December 31, 2014 Statutory federal income tax rate 34 % 34 % State income taxes, net of federal taxes 9 % 9 % Valuation allowance (43 )% (43 )% Effective income tax rate 0 % 0 % As of March 31, 2016, the Company has a net operating loss carryforward of approximately $976,000 to reduce future federal and state taxable income through 2035. The Company currently has no federal or state tax examinations in progress, nor has it had any federal or state examinations since its inception. All of the Company's open tax years beginning in tax year 2013 are subject to federal and state tax examinations.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2016
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	Note 10. RELATED PARTY TRANSACTIONS In August 2015, the Company acquired 100% of the issued and outstanding common stock of Medical Lasers Manufacturer, Inc. ("MLM") from a stockholder and officer of the Company for 20,000 common shares which were valued at $0.015 per share. All intercompany transactions were eliminated during consolidation. As more fully described in Note 4 to the Consolidated Financial Statements, the Company owed the following amounts to related parties as of March 31: 2016 2015 Due to Related Party $ 8,921 $ 8,921 Due to Officer/Stockholder 8,446 8,446 Due to other Stockholders 3,113 55,199 Total Related Party Obligations $ 20,480 $ 72,566 The company has entered into an employment agreement with its Chief Executive Officer (CEO) for the five year period beginning January 1, 2012. The agreement provides for base compensation, annual bonus, benefits, vacation and reimbursements. Under this agreement, the base compensation of the Company's CEO is $100,000 per annum which has been accrued for the years ended December 13, 2015 and 2014 and $25,000 has been accrued for the quarter ended March 31, 2016. For the quarter ended March 31, 2016, $18,974 in accrued compensation was paid. Accrued compensation in the amount of $30,000 was converted to shares of common stock during 2015. In August 2015, MLM acquired a trademark from the son of the Company’s President for $20,000 due 90 days from the date of acquisition. As of March 31, 2016, no payment has been made on this liability. The $20,000 liability is included in the balance sheet under “Accounts payable and accrued expenses” at March 31, 2016 and December 31, 2015. Due to the uncertainty of future cash flows from the trademark management has deemed it to be impaired and has recorded an impairment expense of $20,000 at September 30, 2015 In August 2015, subsequent to the date the Company acquired MLM, MLM purchased $50,000 in inventory from the son of the Company's President. The $50,000 liability is included in the balance sheet under “Accounts payable and accrued expenses” at December 31, 2015. During the quarter-ended March 31, 2016, 10,000 shares of Series B Preferred stock were issued in settlement of this liability. As more fully described in Note 1-Intangible Asset-Licensing Agreement, on March 8 th

Basis of Reporting - Going Conc

Basis of Reporting - Going Concern	3 Months Ended
	Mar. 31, 2016
Basis of Reporting - Going Concern [Abstract]
BASIS OF REPORTING - GOING CONCERN	Note 11. BASIS OF REPORTING - GOING CONCERN The accompanying financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the recoverability of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred losses from inception of approximately $1,304,222, which, among other factors, raises substantial doubt about the Company's ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon management's plans to raise additional capital from the sale of stock and receive additional loans from related parties. The accompanying financial statements do not include any adjustments that might be required should the Company be unable to continue as a going concern.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2016
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	Note 12. SUBSEQUENT EVENTS On April 15, 2016 the Company entered into a Business Consulting Agreement with a Michigan limited liability company ("Consultant"). The agreement provides for the Company retaining the Consultant for 125 days for general business and product development services. The Consultant shall be paid $750 per month in cash and 500,000 shares of common stock of the Company valued at $5,000 as of the effective date and another 500,000 common shares upon determination of the Company in its sole and absolute discretion. On April 18, 2016 the company issued 1,100,000 shares of common stock in conversion of 2,200 shares of Preferred Series B stock. On May 2, 2016, the Company issued to an Investor a convertible redeemable note in the principal amount of $57,750 ("the Note"). The Note, which matures on May 2, 2017, pays interest at the rate of 8% per annum. The note contains a 10% original issue discount. The holder of the note is entitled, at its option beginning on the 6-month anniversary, to convert all or any of the principal face amount of the Note then outstanding into shares of the Company's common stock at the price equal to 55% of the lowest trading price for the twenty prior trading days including the date of conversion. On May 2, 2016, the Company issued to an Investor a replacement redeemable convertible note in the principal amount of $60,000 ("the Replacement Note"). The Note, which matures on May 2, 2017, pays interest at the rate of 8% per annum. This Replacement Note partially replaces a note originally issued on June 12, 2015 in the principal amount of $100,000 The holder of the note is entitled, at its option beginning on the 6-month anniversary, to convert all or any of the principal face amount of the Note then outstanding into shares of the Company's common stock at the price equal to 55% of the lowest trading price for the twenty prior trading days including the date of conversion. On May 10, 2016 a noteholder elected to partially convert $7,241 of an outstanding convertible note payable into 2,194,200 shares of common stock. The principal balance due under the note payable after the conversion is $52,759. On May 4, 2016 a noteholder elected to partially convert $8,800 of an outstanding convertible note payable into 2,000,000 shares of common stock. The principal balance due remaining under the note payable after the conversion is $26,200. On May 11, 2016 the Company amended a Convertible Debenture originally issued June 12, 2015 in remaining unassigned principal amount of $45,000. The Company issued 300,000 shares to the debenture holder for the main purpose of extending the maturity date to one year from the date of the amendment.

Nature of Operations and Summ20

Nature of Operations and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2016
Nature of Operations and Summary of Significant Accounting Policies [Abstract]
Organization	Organization Medifirst Solutions, Inc. ("MSI" or the "Company") was incorporated in Nevada in November 2010. The Company has not generated significant sales to date. The Company intends to have a diverse product line of consumer products. Since inception, the Company has been engaged in business planning activities, including researching the industry, identifying target markets for the Company's products, developing the Company's models and financial forecasts, performing due diligence regarding potential geographic locations most suitable for establishing the Company's offices and identifying future sources of capital. At the present time, the Company is building products and affiliations in and related to the cosmetic healthcare industry. Pursuant to a sale and purchase agreement dated August 19, 2015 between the Company and the Company's president, the Company acquired 100% of the equity interests in Medical Lasers Manufacturer, Inc. ("MLM") with the total purchase price of 20,000 shares of the Company's common stock at $0.001 per share (or $20). The fair value of the acquired entity was $20. The transaction was considered as a business acquisition and accordingly the acquisition method of accounting has been applied. MLM had no assets at the date of the business combination. The Consolidated financial statements include the accounts of MSI and its only wholly owned subsidiary, MLM. All material intercompany balances and transactions have been eliminated in consolidation. The Company’s activities are subject to significant risks and uncertainties, including failing to secure additional funding to operationalize the Company’s current technology.
Basis of Presentation	Basis of Presentation The accompanying unaudited financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted pursuant to such principles and regulations of the Securities and Exchange Commission for Form 10-Q. All adjustments, consisting of normal recurring adjustments, have been made which, in the opinion of management, are necessary for a fair presentation of the results of interim periods. The results of operations for such interim periods are not necessarily indicative of the results that may be expected for a full year because of, among other things, seasonality factors in the retail business. The unaudited financial statements contained herein should be read in conjunction with the audited financial statements and notes thereto for the fiscal year ended December 31, 2015.
Revenue Recognition	Revenue Recognition In general, the Company records revenue when persuasive evidence of an arrangement exists, services have been rendered or product delivery has occurred, the sales price to the customer is fixed or determinable, and collectability is reasonably assured. The following policies reflect specific criteria for the various revenues streams of the Company: Revenue is recognized at the time the product is delivered or services are performed. Provision for sales returns are estimated based on the Company's historical return experience. Revenue is presented net of returns.
Notes receivable (Investor)	Notes receivable (Investor) In January 2016 the company entered into a securities purchase agreement with an investor (as more fully described in Note 5 below). As part of that agreement, the company issued convertible 8% notes payable to the investor in the amounts of $105,000, $50,000, $50,000 and $46,803. Two of these notes will close subsequent to March 31, 2016 and are secured by fully collateralized promissory notes issued by the Investor to the Company in the total amount of $96,803 ($50,000 and $46,803 - also known as the "back-end notes") and are reported in the balance sheet at $93,130 net of legal fees in the amount of $4,840 plus accrued interest of $1,167. These notes bear interest at the rate of 8% per annum. Interest income in the amount of $1,167 has been accrued for the quarter ended March 31, 2016 on these back-end notes.
Accounts Receivable	Accounts Receivable The Company extends credit to its customers in the normal course of business and performs ongoing credit evaluations of its customers, maintaining an allowance for potential credit losses. Accounts receivable is reported net of the allowance for doubtful accounts. The allowance is based on management's estimate of the amount of receivables that will actually be collected.
Inventory	Inventory Inventory consists of finished goods and is stated at the lower of cost (first-in, first-out) or market value.
Equipment	Equipment Equipment, consisting of computer equipment, is stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets, of five years.
Long-Lived Assets	Long-Lived Assets The Company reviews long-lived assets, such as equipment, for impairment whenever events or changes in circumstances indicate the carrying amount may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds the estimated future cash flows, an impairment loss will be recorded by the amount the carrying value exceeds the fair value of the asset. In August 2015, the Company's wholly-owned subsidiary MLM, acquired a trademark for $20,000. Due to the uncertainty of future cash flows from the trademark, management has deemed it to be impaired and recorded an impairment expense of $20,000 in September 2015.
Intangible Asset- Licensing Agreement	Intangible Asset- Licensing Agreement On March 8th 2016, the company, through its sole wholly-owned subsidiary ("Licensee"), entered into a Product and Know-How License Agreement ("Agreement") with a Florida Corporation ("Licensor"). This Florida Corporation is owned by a related party – the son of the Company’s CEO. The license provides with respect to the Technology, Licensor hereby grants to Licensee an irrevocable, nontransferable, royalty-bearing license, with a right of sublicense (the “License”), throughout the Territory in the Field of Use, whether or not under the Licensed Patent, to: ● use or submit or deliver the Technology and/or any Product to any regulatory body throughout the Territory for purposes of obtaining approval to make, Sell, offer for Sale, import, export and distribute the Technology or Products; and ● use or copy the Technology and/or any Product; and ● market, make, have made, Sell, offer for Sale, import and distribute Products; and ● sublicense the Technology as set forth in Article 4 below; and ● prepare, or have prepared on its behalf, modifications, enhancements and/or derivative works of the Technology. In connection with the license granted under Section 2.1 above, Licensor hereby grants to Licensee a license to the Licensed Patents, whether now existing or hereafter acquired. The consideration for the licensing agreement consisted of the issuance of 25,000 Series B Preferred stock shares to the Licensor (at par) plus a $150,000 promissory note issued by the Company to the licensor. The last part of the consideration in this license agreement is the royalty payments which have not taken effect yet as they are based on sales for which the company has none. Both the stock issuance and promissory notes have "claw-back" provisions should certain events fail to occur. The licensing agreement is for a ten year period effective from March 8th 2016. The cost of the licensing agreement is being amortized over its ten-year period and charged to income on a straight-line basis.
Debt Issues Costs and Debt Discount	Debt Issues Costs and Debt Discount The Company may pay debt issue costs, and record debt discounts in connection with raising funds through the issuance of convertible debt. These costs are amortized over the life of the debt to interest expense. If a conversion of the underlying debt occurs, a proportionate share of the unamortized amounts is immediately expensed. For March 31, 2016 and retroactively, the Company has early-adopted ASU 2015-03: Simplifying the Presentation of Debt Issuance Costs and has reflected the deferred financing costs as a direct reduction of the related debt (See Note 7 to Consolidated Financial Statements).
Original Issue Discount	Original Issue Discount For certain convertible debt issued, the Company provides the debt holder with an original issue discount. The original issue discount is recorded to debt discount, reducing the face amount of the note and is amortized to interest expense over the life of the debt.
Derivative Liabilities	Derivative Liabilities Fair value accounting requires bifurcation of embedded derivative instruments such as conversion features in convertible debt or equity instruments, and measurement of their fair value for accounting purposes. The Company assessed its securities for purposes of determining the proper accounting treatment and valuation as set forth in the Statement of Financial Accounting Standard ASC 820–10–35–37 Fair Value in Financial Instruments Accounting for Derivative Instruments and Hedging Activities In assessing the convertible debt instruments, management determines if the convertible debt host instrument is conventional convertible debt and further if there is a beneficial conversion feature requiring measurement. If the instrument is not considered conventional convertible debt, the Company will continue its evaluation process of these instruments as derivative financial instruments. Once the derivative liabilities are determined, they are adjusted to reflect fair value at each reporting period end, with any increase or decrease in the fair value being recorded in results of operations as an adjustment to fair value of derivatives.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the condensed consolidated balance sheets and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.
Financial Instruments	Financial Instruments The carrying amounts reported in the balance sheets for cash, accounts receivable, accounts payable, and other accrued liabilities approximate their fair values.
Segment Information	Segment Information The Company follows Accounting Standards Codification ("ASC") 280, "Segment Reporting". The Company currently operates in a single segment and will evaluate additional segment disclosure requirements as it expands its operations.
Net Income (Loss) Per Common Share	Net Income (Loss) Per Common Share The Company calculates net income (loss) per share based on the authoritative guidance. Basic earnings (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Diluted earnings (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares and dilutive common stock equivalents outstanding. During periods in which the Company incurs losses, common stock equivalents, if any, are not considered, as their effect would be anti-dilutive.
Income Taxes	Income Taxes The Company utilizes the accrual method of accounting for income taxes. Under the accrual method, deferred tax assets and liabilities are determined based on the differences between the financial reporting basis and the tax basis of the assets and liabilities, and are measured using enacted tax rates and laws that will be in effect when the differences are expected to reverse. An allowance against deferred tax assets is recognized, when it is more likely than not, that such tax benefits will not be realized. The Company recognizes the financial statement benefit of an uncertain tax position only after considering the probability that a tax authority would sustain the position in an examination. For tax positions meeting a “more-likely-than-not” threshold, the amount recognized in the financial statements is the benefit expected to be realized upon settlement with the tax authority. For tax positions not meeting the threshold, no financial statement benefit is recognized. The Company recognizes interest and penalties, if any, related to uncertain tax positions in income tax expense. The Company did not have any unrecognized tax benefits as of March 31, 2016, and does not expect this to change significantly over the next 12 months.
Stock-Based Compensation	Stock-Based Compensation The Company accounts for equity instruments issued to employees in accordance with ASC 718, Compensation - Stock Compensation. ASC 718 requires all share-based compensation payments to be recognized in the financial statements based on the fair value on the issuance date. Equity instruments granted to non-employees are accounted for in accordance with ASC 505, Equity. The final measurement date for the fair value of equity instruments with performance criteria is the date that each performance commitment for such equity instrument is satisfied or there is a significant disincentive for non-performance.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At March 31, 2016, the Company had $203,353 in cash equivalents.
Recent Pronouncements	Recent Pronouncements In May 2014, FASB and IASB issued a new joint revenue recognition standard that supersedes nearly all GAAP guidance on revenue recognition. The core principle of the standard is that revenue recognition should depict the transfer of goods and services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. The new standard is effective for the Company for the fiscal year beginning after December 15, 2017. The Company is currently evaluating the impact of this ASU on the consolidated financial statements. On January 05, 2016, the FASB completed its Classification and Measurement of Financial Instruments project by issuing ASU No. 2016-01, Financial Instruments—Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. The new guidance improves certain aspects of recognition, measurement, presentation and disclosure of financial instruments. For public business entities, the new guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The Company does not believe the impact of its pending adoption of this ASU on the Company’s consolidated financial statements will be material. In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, “Leases” (Topic 842), which requires lessees to recognize the following for all leases (with the exception of short-term leases) at the commencement date: a lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and a right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. The revised guidance must be applied on a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. The revised guidance is effective for the Company beginning in the quarter ending March 31, 2019. The Company is currently evaluating the impact of this ASU on the consolidated financial statements. In April 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-10, “Revenue from Contracts with Customers” (Topic 606), which requires entities to identify performance obligations and recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The ASU also includes implementation guidance on determining whether an entity’s promise to grant a license provides a customer with either a right to use the entity’s intellectual property (which is satisfied at a point in time) or a right to access the entity’s intellectual property (which is satisfied over time). The amendments in this Update affect the guidance in Accounting Standards Update 2014-09, Revenue from Contracts with Customers (Topic 606), which is not yet effective. The effective date and transition requirements for the amendments in this Update are the same as the effective date and transition requirements in Topic 606 (and any other Topic amended by Update 2014-09). Accounting Standards Update 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, defers the effective date of Update 2014-09 by one year. The Company is currently evaluating the impact of this ASU on the consolidated financial statements. The Company acknowledges the recent accounting pronouncements issued during the quarter-ended March 31, 2016 by the FASB in the form of Accounting Standards Updates (“ASUs”) numbered ASU 2016-08, 09, 11 and ASU 2016-12 providing guidance and related to revenue clarifications. The Company believes these pronouncements, when effective, will not have a material impact on the financial statements.

Property, Plant and Equipment21

Property, Plant and Equipment (Net)(Tables)	3 Months Ended
	Mar. 31, 2016
Property, Plant and Equipment (Net) [Abstract]
Summary of equipment recorded at cost	March 31, 2016 December 31, 2015 Computer equipment $ 8,314 $ 8,314 Less: accumulated depreciation (6,501 ) (6,155 ) $ 1,814 $ 2,159

Convertible Notes Payable (Tabl

Convertible Notes Payable (Tables)	3 Months Ended
	Mar. 31, 2016
Short-term Debt [Line Items]
Schedule of derivative liabilities	Debt Face Amount Original Issue Discount Derivative Discount Deferred Financing Costs Total Convertible Notes Payable Derivative Liability Note Payable - BS $ 125 $ 125 Note Payable - SF 60 60 Note Payable - MC #1 2,075 2,075 Note Payable - NW 3,715 3,715 Note Payable - MC #2 3,000 3,000 Debenture Payable (5%) - B 100,000 100,000 32,293 Convertible Note Payable - LGC (8%) 105,000 (15,397 ) (78,310 ) (7,162 ) 4,130 123,003 Convertible Note Payable - LGC (8%) 50,000 (44,708 ) (1,925 ) 3,367 89,897 Convertible Note Payable - LGC (8%) 50,000 (46,712 ) (2,336 ) 952 88,709 Convertible Note Payable - LGC (8%) 46,803 (43,146 ) (2,186 ) 1,471 83,216 Convertible Note Payable - CB (5%) 35,000 (2,699 ) (540 ) 31,762 Convertible Note Payable - LGC (8%) 31,000 (781 ) (22,861 ) (2,473 ) 4,886 56,366 Convertible Notes Payable- VVtoLG (8%) 49,491 1,358 50,849 59,209 Convertible Notes Payable- VV (8%) #2 38,000 (680 ) 37,320 $ 514,269 $ (18,877 ) $ (234,379 ) $ (17,301 ) $ 243,713 $ 532,693
Converted note 110 [Member]
Short-term Debt [Line Items]
Summary of convertible note conversion detail	Date of Conversion Principal Amount Converted Conversion Rate Shares Received June 2013 $ 70 $ 0.0001 700,000 August 2013 $ 40 $ 0.0001 400,000
Converted note additional 90 [Member]
Short-term Debt [Line Items]
Summary of convertible note conversion detail	Date of Conversion Principal Amount Converted Conversion Rate Shares Received November 2013 $ 40 $ 0.0001 400,000 December 2013 $ 50 $ 0.0001 500,000
Converted note additional 90 one [Member]
Short-term Debt [Line Items]
Summary of convertible note conversion detail	Date of Conversion Principal Amount Converted Conversion Rate Shares Received March 2014 $ 50 $ 0.0001 500,000 April 2014 $ 40 $ 0.0001 400,000
Converted note 1,010 [Member]
Short-term Debt [Line Items]
Summary of convertible note conversion detail	Date of Conversion Principal Amount Converted Conversion Rate Shares Received December 2012 $ 150 $ 0.001 $ 150,000 January 2013 $ 660 $ 0.001 $ 660,000 March 2013 $ 200 $ 0.001 $ 200,000

Derivatives and Fair Value In23

Derivatives and Fair Value Instruments (Tables)	3 Months Ended
	Mar. 31, 2016
Derivatives and Fair Value Instruments [Abstract]
Projected annual volatility for each valuation period	12/31/2015 151 % 1/7/2016 222 % 1/12/2016 226 % 2/23/2016 234 % 3/7/2016 227 % 3/11/2016 245 % 3/31/2016 252 %
Summary of convertible notes payable	Convertible Note Derivative Treatment Date Maturity Date Principal Note Amount Original Derivative Valuation Derivative Valuation December 31, 2015 Conversions Mark to Market Derivative Valuation March 31, 2016 8% Convertible Note Payable- issued 10/8/2015 10/8/2015 10/8/2015 $ 31,000 $ 58,779 $ 56,366 $ (4,203 ) $ 52,163 5 % Convertible Note- Payable - issued 6/12/2015 12/9/2015 12/12/2015 100,000 37,827 35,176.00 (2,883 ) 32,293 8% Convertible Notes Payable- issued 6/25/2015 12/22/2015 1/7/2017 59,000 56,956 66,075.00 (10,151.00 ) 3,285 59,209 8% Convertible Notes Payable- issued January 7, 2016 1/7/2016 1/7/2017 105,000 87,287 - 39,919 127,206 8% Convertible Notes Payable- issued January 7, 2016 1/7/2016 1/7/2017 50,000 68,124 - 21,773 89,897 8% Convertible Notes Payable- issued March 7, 2016 3/7/2016 3/7/2017 50,000 87,538 - 1,171 88,709 8% Convertible Notes Payable- issued March 7, 2016 3/7/2016 1/7/2017 46,803 82,115 - 1,101 83,216 $ 441,803 $ 478,626 $ 157,617 $ (10,151 ) $ 60,163 $ 532,693

Income Taxes (Tables)

Income Taxes (Tables)	3 Months Ended
	Mar. 31, 2016
Income Taxes [Abstract]
Schedule of statutory federal and state income tax rates to the loss before income taxes	December 31, 2015 December 31, 2014 Statutory federal income tax rate 34 % 34 % State income taxes, net of federal taxes 9 % 9 % Valuation allowance (43 )% (43 )% Effective income tax rate 0 % 0 %

Related Party Transactions (Tab

Related Party Transactions (Tables)	3 Months Ended
	Mar. 31, 2016
Related Party Transactions [Abstract]
Summary of owed amounts to related parties	2016 2015 Due to Related Party $ 8,921 $ 8,921 Due to Officer/Stockholder 8,446 8,446 Due to other Stockholders 3,113 55,199 Total Related Party Obligations $ 20,480 $ 72,566

Nature of Operations and Summ26

Nature of Operations and Summary of Significant Accounting Policies (Details)	1 Months Ended		3 Months Ended
	Sep. 30, 2015USD ($)	Aug. 19, 2015USD ($)$ / sharesshares	Mar. 31, 2016USD ($)Segmentshares	Mar. 31, 2015USD ($)	Mar. 07, 2016	Feb. 29, 2016USD ($)	Jan. 13, 2016USD ($)	Jan. 07, 2016	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)	Dec. 31, 2012
Nature of Operations and Summary of Significant Accounting Policies (Textual)
Number of operating Segment | Segment			1
Cash equivalents			$ 203,353	$ 2,430					$ 156,958
Estimated useful lives of the assets			Five years.
Impairment of trademark	$ 20,000
Impairment expense	$ 20,000
Equity method investment, ownership percentage		100.00%
Fair value of acquired entity		$ 20
Total purchase price, Per share | $ / shares		$ 0.001
Convertible notes payable to investor, Face amount			$ 514,269						$ 441,803
Interest rate			20.00%		8.00%			8.00%
Total purchase price | shares		20,000
Notes receivable (investor)			$ 93,130
Legal fees			4,840
Accrued interest			1,167
Interest income			$ 1,167
Series B Preferred Stock
Nature of Operations and Summary of Significant Accounting Policies (Textual)
Issuance of Series B Preferred shares as part consideration for license agreement, Shares | shares			25,000
Investor [Member]
Nature of Operations and Summary of Significant Accounting Policies (Textual)
Convertible notes payable to investor, Face amount							$ 50,000
Promissory notes, Description			Two of these notes will close subsequent to March 31, 2016 and are secured by fully collaterlized promissory notes issued by the Investor to the Company in the total amount of $96,803 ($50,000 and $46,803 - also know as the "back-end notes").
8 % Convertible Notes Payable [Member]
Nature of Operations and Summary of Significant Accounting Policies (Textual)
Convertible notes payable to investor, Face amount			$ 105,000
8 % Convertible Notes Payable One [Member]
Nature of Operations and Summary of Significant Accounting Policies (Textual)
Convertible notes payable to investor, Face amount			50,000
8 % Convertible Notes Payable Two [Member]
Nature of Operations and Summary of Significant Accounting Policies (Textual)
Convertible notes payable to investor, Face amount			50,000
8 % Convertible Notes Payable Three [Member]
Nature of Operations and Summary of Significant Accounting Policies (Textual)
Convertible notes payable to investor, Face amount			$ 46,803
Promissory Note [Member]
Nature of Operations and Summary of Significant Accounting Policies (Textual)
Interest rate			8.00%			6.00%					10.00%
Promissory note issued by company			$ 150,000			$ 7,000

Property, Plant and Equipment27

Property, Plant and Equipment (Net) (Details) - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Property, Plant and Equipment (Net) [Abstract]
Computer equipment	$ 8,314	$ 8,314
Less: accumulated depreciation	(6,501)	(6,155)
Property, plant and equipment, net	$ 1,813	$ 2,159

Property, Plant and Equipment28

Property, Plant and Equipment (Net) (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Property Plant and Equipment (Net) (Textual)
Depreciation expense	$ 346	$ 416

Due to Related Party (Details)

Due to Related Party (Details) - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Due to Related Party (Textual)
Due to related party	$ 8,921	$ 8,921

Loans Payable - Stockholders (D

Loans Payable - Stockholders (Details) - USD ($)	Jan. 07, 2016	Feb. 29, 2016	Jan. 31, 2016	Dec. 31, 2012	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015	Dec. 31, 2014	Mar. 07, 2016
Loans payable stockholders (Textual)
Loans payable - stockholders					$ 10,680
Shareholders advance					0	$ 20,670
Shareholder indebted amount					$ 1,200	4,600
Interest rate on loan	8.00%				20.00%				8.00%
Maturity date	Jan. 7, 2017				Jul. 2, 2012
Principal amount converted	$ 105,000		$ 251,803
Loan balance					$ 100	500
Stockholder [Member]
Loans payable stockholders (Textual)
Shareholder indebted amount					$ 1,500	$ 1,500
Interest rate on loan					26.70%
Maturity date					Jan. 1, 2014
Conversion Rate					$ 0.0001
Promissory Note [Member]
Loans payable stockholders (Textual)
Shareholder indebted amount				$ 5,000
Interest rate on loan		6.00%		10.00%	8.00%
Maturity date		Feb. 4, 2017		Jun. 2, 2013
Principal amount converted							$ 2,400	$ 2,500
Shares issued on conversion of convertible notes							2,400,000	2,500,000
Note outstanding		$ 7,000
Promissory note issued by company		$ 7,000			$ 150,000

Convertible Notes Payable (Deta

Convertible Notes Payable (Details) - USD ($)	Jan. 07, 2016	Jan. 31, 2016	Mar. 31, 2016
Summary of convertible note conversion detail
Principal Amount Converted	$ 105,000	$ 251,803
June 2013 [Member] | Converted note 110 [Member]
Summary of convertible note conversion detail
Principal Amount Converted			$ 70
Conversion Rate			$ 0.0001
Shares Received			700,000
August 2013 [Member] | Converted note 110 [Member]
Summary of convertible note conversion detail
Principal Amount Converted			$ 40
Conversion Rate			$ 0.0001
Shares Received			400,000

Convertible Notes Payable (De32

Convertible Notes Payable (Details 1) - USD ($)	Jan. 07, 2016	Jan. 31, 2016	Mar. 31, 2016
Summary of convertible note conversion detail
Principal Amount Converted	$ 105,000	$ 251,803
November 2013 [Member] | Converted note additional 90 [Member]
Summary of convertible note conversion detail
Principal Amount Converted			$ 40
Conversion rate			$ 0.0001
Shares Received			400,000
December 2013 [Member] | Converted note additional 90 [Member]
Summary of convertible note conversion detail
Principal Amount Converted			$ 50
Conversion rate			$ 0.0001
Shares Received			500,000

Convertible Notes Payable (De33

Convertible Notes Payable (Details 2) - USD ($)	Jan. 07, 2016	Jan. 31, 2016	Mar. 31, 2016
Summary of convertible note conversion detail
Principal Amount Converted	$ 105,000	$ 251,803
March 2014 [Member] | Converted note additional 90 one [Member]
Summary of convertible note conversion detail
Principal Amount Converted			$ 50
Conversion rate			$ 0.0001
Shares Received			500,000
April 2014 [Member] | Converted note additional 90 one [Member]
Summary of convertible note conversion detail
Principal Amount Converted			$ 40
Conversion rate			$ 0.0001
Shares Received			400,000

Convertible Notes Payable (De34

Convertible Notes Payable (Details 3) - USD ($)	Jan. 07, 2016	Jan. 31, 2016	Mar. 31, 2016
Summary of convertible note conversion detail
Principal Amount Converted	$ 105,000	$ 251,803
December 2012 [Member] | Converted note 1,010 [Member]
Summary of convertible note conversion detail
Principal Amount Converted			$ 150
Conversion Rate			$ 0.001
Shares Received			150,000
January 2013 [Member] | Converted note 1,010 [Member]
Summary of convertible note conversion detail
Principal Amount Converted			$ 660
Conversion Rate			$ 0.001
Shares Received			660,000
March 2013 [Member] | Converted note 1,010 [Member]
Summary of convertible note conversion detail
Principal Amount Converted			$ 200
Conversion Rate			$ 0.001
Shares Received			200,000

Convertible Notes Payables (Det

Convertible Notes Payables (Details 4) - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Short-term Debt [Line Items]
Face Amount	$ 514,269	$ 441,803
Original Issue Discount	(18,877)
Derivative Discount	(234,379)
Deferred Financing Costs	(17,301)
Total Convertible Notes Payable	243,713	180,393
Derivative Liability	532,693	157,617
Note Payable - BS [Member]
Short-term Debt [Line Items]
Face Amount	$ 125
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	$ 125
Derivative Liability
Note Payable - SF [Member]
Short-term Debt [Line Items]
Face Amount	$ 60
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	$ 60
Derivative Liability
Note Payable - MC #1 [Member]
Short-term Debt [Line Items]
Face Amount	$ 2,075
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	$ 2,075
Derivative Liability
Note Payable - NW [Member]
Short-term Debt [Line Items]
Face Amount	$ 3,715
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	$ 3,715
Derivative Liability
Note Payable - MC #2 [Member]
Short-term Debt [Line Items]
Face Amount	$ 3,000
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	$ 3,000
Derivative Liability
Debenture Payable (5%) - B [Member]
Short-term Debt [Line Items]
Face Amount	$ 100,000
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	$ 100,000
Derivative Liability	32,293
Convertible Note Payable - LGC (8%) 1 [Member]
Short-term Debt [Line Items]
Face Amount	105,000	100,000
Original Issue Discount	(15,397)
Derivative Discount	(78,310)
Deferred Financing Costs	(7,162)
Total Convertible Notes Payable	4,130	100,000
Derivative Liability	32,293	35,176
Convertible Note Payable - LGC (8%) 2 [Member]
Short-term Debt [Line Items]
Face Amount	50,000
Derivative Discount	(44,708)
Deferred Financing Costs	(1,925)
Total Convertible Notes Payable	3,367
Derivative Liability	89,897
Convertible Note Payable - LGC (8%) 3 [Member]
Short-term Debt [Line Items]
Face Amount	50,000	31,000
Derivative Discount	(46,712)
Deferred Financing Costs	(2,336)
Total Convertible Notes Payable	952	31,000
Derivative Liability	52,163	56,366
Convertible Note Payable - LGC (8%) 4 [Member]
Short-term Debt [Line Items]
Face Amount	46,803	59,000
Derivative Discount	(43,146)
Deferred Financing Costs	(2,186)
Total Convertible Notes Payable	1,471	59,000
Derivative Liability	59,209	$ 66,075
Convertible Note Payable - CB (5%) [Member]
Short-term Debt [Line Items]
Face Amount	35,000
Original Issue Discount	$ (2,699)
Derivative Discount
Deferred Financing Costs	$ (540)
Total Convertible Notes Payable	$ 31,762
Derivative Liability
Convertible Note Payable - LGC (8%) [Member]
Short-term Debt [Line Items]
Face Amount	$ 31,000
Original Issue Discount	(781)
Derivative Discount	(22,861)
Deferred Financing Costs	(2,473)
Total Convertible Notes Payable	4,886
Derivative Liability	56,366
Convertible Notes Payable- VVtoLG (8%) [Member]
Short-term Debt [Line Items]
Face Amount	$ 49,491
Original Issue Discount
Derivative Discount	$ 1,358
Deferred Financing Costs
Total Convertible Notes Payable	$ 50,849
Derivative Liability	59,209
Convertible Notes Payable- VV (8%) #2 [Member]
Short-term Debt [Line Items]
Face Amount	$ 38,000
Original Issue Discount
Derivative Discount
Deferred Financing Costs	$ (680)
Total Convertible Notes Payable	$ 37,320
Derivative Liability

Convertible Notes Payable (De36

Convertible Notes Payable (Details Textual 1) - USD ($)	May. 05, 2016	May. 04, 2016	Apr. 05, 2016	Jan. 07, 2016	Jun. 30, 2014	Jan. 31, 2016	Apr. 30, 2015	Oct. 31, 2014	Mar. 31, 2014	Dec. 31, 2013	Nov. 30, 2013	Oct. 31, 2013	Sep. 30, 2013	Aug. 31, 2013	Jul. 31, 2013	May. 31, 2012	Mar. 31, 2011	Apr. 30, 2014	Mar. 31, 2016	May. 10, 2016	Dec. 31, 2015	May. 11, 2016	Mar. 07, 2016	Dec. 31, 2014
Convertible Notes Payable (Textual)
Convertible notes payable to investor, Face amount																			$ 514,269		$ 441,803
Principal amount transferred to Shareholders/Third party														$ 330
Amount of accrued interest transfered														$ 55
Interest rate on notes				8.00%															20.00%				8.00%
Principal amount converted				$ 105,000		$ 251,803
Subsequent Event [Member]
Convertible Notes Payable (Textual)
Convertible notes payable to investor, Face amount																						$ 45,000
Shares issued on conversion of convertible notes	768,026	2,000,000	783,062																	2,194,200
Principal amount converted	$ 2,800	$ 8,800	$ 3,000																	$ 7,241
6% Convertible Notes Payable [Member]
Convertible Notes Payable (Textual)
Maturity of convertible notes																	January 2,012
Interest rate on notes																	6.00%
Issued aggregate principal amount																	$ 800
Converted note 110 [Member]
Convertible Notes Payable (Textual)
Convertible notes payable to investor, Face amount																			$ 105,000
Shares issued on conversion of convertible notes													1,000,000	50,000					1,100,000
Principal amount converted													$ 100	$ 5					$ 110
Remaining principal of note																					3,715
Converted note 110 [Member] | Third Party [Member]
Convertible Notes Payable (Textual)
Shares issued on conversion of convertible notes													350,000
Principal amount converted													$ 35
Converted note additional 90 [Member]
Convertible Notes Payable (Textual)
Convertible notes payable to investor, Face amount																			50,000
Shares issued on conversion of convertible notes									900,000	900,000	900,000							900,000
Principal amount converted									$ 90	$ 90	$ 90							$ 90
Remaining principal of note																			$ 125,000
Description of conversion of convertible notes																		The holder of the note has the right to convert the principal into shares of the Company's common stock at any time 180 days after the closing date at $0.0001 per share.
$240 Note [Member]
Convertible Notes Payable (Textual)
Conversion rate															$ 0.0006
Shares issued on conversion of convertible notes															400,000
Principal amount converted															$ 240
Remaining principal of note																					$ 60			$ 60
Description of conversion of convertible notes																					The notes plus any accrued but unpaid interest are convertible at the rate of $0.0001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock, or 3,506,665 shares at December 31, 2015.
$25,000 Note [Member]
Convertible Notes Payable (Textual)
Maturity of convertible notes																November 2,012
Note conversion, maximum shares issuable in percentage of issued and outstanding common stock																9.99%
Retired amount of notes															$ 14,000
Interest rate on notes																6.00%
Conversion rate																$ 0.001
Shares issued on conversion of convertible notes																1,010,000
Principal amount converted																$ 1,010
Description of conversion of convertible notes																The note plus any accrued but unpaid interest were convertible at the rate of $0.001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock.
Issued aggregate principal amount																$ 25,000
$300 Note [Member]
Convertible Notes Payable (Textual)
Shares issued on conversion of convertible notes															300,000
Principal amount converted														$ 4,475	$ 300
Remaining principal of note															$ 9,690
$400 Note [Member]
Convertible Notes Payable (Textual)
Note conversion, maximum shares issuable in percentage of issued and outstanding common stock																					9.99%
Interest rate on notes																					3,506,665
Conversion rate								$ 0.001				$ 0.001									$ 0.0001
Shares issued on conversion of convertible notes												400,000
Principal amount converted												$ 400
$700 Note [Member]
Convertible Notes Payable (Textual)
Note conversion, maximum shares issuable in percentage of issued and outstanding common stock																			9.99%
Interest rate on notes																			4,154,729
Principal amount transferred to Shareholders/Third party												$ 1,000
Conversion rate														$ 0.001					$ 0.001
Shares issued on conversion of convertible notes					700,000									700,000
Principal amount converted					$ 700									$ 700
Remaining principal of note																			$ 2,075
Description of conversion of convertible notes														The note plus any accrued but unpaid interest are convertible at the rate of $0.001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock, or 3,506,665 shares at December 31, 2015.
$1,100 Note [Member]
Convertible Notes Payable (Textual)
Note conversion, maximum shares issuable in percentage of issued and outstanding common stock																			9.99%
Interest rate on notes																			4,154,729
Conversion rate																			$ 0.001
Shares issued on conversion of convertible notes								1,100,000
Principal amount converted								$ 1,100
$3,000 Note [Member]
Convertible Notes Payable (Textual)
Maturity of convertible notes							October 2,015
Interest rate on notes							8.00%
Conversion rate							$ 0.0001
Issued aggregate principal amount							$ 3,000

Convertible Note Payable (Detai

Convertible Note Payable (Details Textual 2) - USD ($)	Jan. 07, 2016	Oct. 08, 2015	Aug. 31, 2015	Jul. 31, 2015	Mar. 31, 2016	Mar. 07, 2016	Dec. 31, 2015
8% Convertible notes payable (Textual)
Convertible notes payable to investor, Face amount					$ 514,269		$ 441,803
Interest rate on notes	8.00%				20.00%	8.00%
Maturity date	Jan. 7, 2017				Jul. 2, 2012
8% Convertible Notes Payable [Member]
8% Convertible notes payable (Textual)
Convertible notes payable to investor, Face amount		$ 31,000	$ 38,000	$ 59,000
Interest rate on notes		8.00%	8.00%	8.00%
Maturity date		Oct. 8, 2016	Mar. 31, 2016	Mar. 31, 2016
Conversion date, description		The note holder has has the right at any time to convert any part or all of the outstanding unpaid principal balance into shares of the Company's common stock at the discounted rate of 58% of the lowest market trading price during the 20 days prior to and including the conversion date.	Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outstanding principal balance into shares of the Company's common stock at the discounted rate of 55% of the average of the three lowest market trading prices during the 10 days immediately preceding the conversion date.	Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outstanding principal balance into shares of the Company's common stock at the discounted rate of 55% of the average of the three lowest market trading prices during the 10 days immediately preceding the conversion date.

Convertible Notes Payables (D38

Convertible Notes Payables (Details Textual 3)

May. 05, 2016shares

May. 04, 2016shares

Apr. 05, 2016shares

Jan. 13, 2016USD ($)

Jan. 07, 2016USD ($)Days$ / shares

Oct. 15, 2015USD ($)

Jun. 30, 2015USD ($)

Mar. 31, 2016USD ($)shares

May. 10, 2016shares

Jun. 15, 2016USD ($)

May. 11, 2016USD ($)

Mar. 15, 2016USD ($)

Mar. 07, 2016

Dec. 31, 2015USD ($)

5% Convertible notes payable (Textual)

Convertible notes payable to investor, Face amount

$ 514,269

$ 441,803

Interest rate on notes

8.00%

20.00%

8.00%

Maturity date

Jan. 7, 2017

Jul. 2, 2012

Sale of convertible redeemable principal amount

$ 50,000

Proceeds from discount on legal fees

$ 75,697

Beneficial ownership interest rate

9.99%

Common Stock [Member]

5% Convertible notes payable (Textual)

Conversion rate | $ / shares

$ 55

Common stock conversion of trading days | Days

20

Subsequent Event [Member]

5% Convertible notes payable (Textual)

Convertible notes payable to investor, Face amount

$ 45,000

Convertible notes payable converted into common stock | shares

768,026

2,000,000

783,062

2,194,200

Sale of convertible redeemable principal amount

$ 46,803

Investor [Member]

5% Convertible notes payable (Textual)

Convertible notes payable to investor, Face amount

50,000

Sale of convertible redeemable principal amount

$ 251,803

Debt instrument convertible redeemable description

(i) a convertible redeemable note in principal amount of $105,000 containing an original issue discount of $20,000 (the "$105K Note"); and (ii) a convertible redeemable note in principal amount of $50,000 (the "$50K Note" and together with the $105K Note, the "Notes").

collateralized secured promissory note

$ 50,000

5% CONVERTIBLE NOTES PAYABLE

5% Convertible notes payable (Textual)

Convertible notes payable to investor, Face amount

$ 35,000

$ 100,000

Interest rate on notes

5.00%

5.00%

Maturity date

Oct. 15, 2016

Dec. 31, 2015

Conversion date, description

Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company's common stock at the discounted rate of 50% of the average of the three lowest market trading prices during the 3 days immediately preceding the conversion date.

Original issue debt discount

$ 5,000

Debt discounted rate, Percentage

55.00%

Convertible notes payable converted into common stock | shares

136,333,000

Derivatives and Fair Value In39

Derivatives and Fair Value Instruments (Details)	3 Months Ended
	Mar. 31, 2016
12/31/2015 [Member]
Projected annual volatility for each valuation period
Volatility rate	151.00%
1/7/2016 [Member]
Projected annual volatility for each valuation period
Volatility rate	222.00%
1/12/2016 [Member]
Projected annual volatility for each valuation period
Volatility rate	226.00%
2/23/2016 [Member]
Projected annual volatility for each valuation period
Volatility rate	234.00%
3/7/2016 [Member]
Projected annual volatility for each valuation period
Volatility rate	227.00%
3/11/2016 [Member]
Projected annual volatility for each valuation period
Volatility rate	245.00%
3/31/2016 [Member]
Projected annual volatility for each valuation period
Volatility rate	252.00%

Derivatives and Fair Value In40

Derivatives and Fair Value Instruments (Details 1) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2016	Dec. 31, 2015
Summary of convertible notes payable
Principal Note Amount	$ 514,269	$ 441,803
Original Derivitive Valuation		478,626
Conversions	(10,151)
Mark to Market	60,163
Derivative Value	532,693	$ 157,617
8% Convertible Note Payable-issued 10/8/2015 [Member]
Summary of convertible notes payable
Derivitive Treatment Date		Oct. 8, 2015
Maturity Date		Oct. 8, 2015
Principal Note Amount	$ 50,000	$ 31,000
Original Derivitive Valuation		58,779
Conversions
Mark to Market	$ (4,203)
Derivative Value	52,163	$ 56,366
5% Convertible Note Payable-issued 6/12/15 [Member]
Summary of convertible notes payable
Derivitive Treatment Date		Dec. 9, 2015
Maturity Date		Dec. 12, 2015
Principal Note Amount	$ 105,000	$ 100,000
Original Derivitive Valuation		37,827
Conversions
Mark to Market	$ (2,883)
Derivative Value	32,293	$ 35,176
8% Convertible Note Payable-issued 6/25/15 [Member]
Summary of convertible notes payable
Derivitive Treatment Date		Dec. 22, 2015
Maturity Date		Jan. 7, 2017
Principal Note Amount	46,803	$ 59,000
Original Derivitive Valuation		56,956
Conversions	(10,151)
Mark to Market	3,285
Derivative Value	$ 59,209	$ 66,075
8% Convertible Notes Payable- issued January 7, 2016 [Member]
Summary of convertible notes payable
Derivitive Treatment Date		Jan. 7, 2016
Maturity Date		Jan. 7, 2017
Principal Note Amount		$ 105,000
Original Derivitive Valuation		$ 87,287
Conversions
Mark to Market	$ 39,919
Derivative Value	$ 127,206
8% Convertible Notes Payable- issued January 7, 2016 [Member]
Summary of convertible notes payable
Derivitive Treatment Date		Jan. 7, 2016
Maturity Date		Jan. 7, 2017
Principal Note Amount		$ 50,000
Original Derivitive Valuation		$ 68,124
Conversions
Mark to Market	$ 21,773
Derivative Value	$ 89,897
8% Convertible Notes Payable- issued March 7, 2016 [Member]
Summary of convertible notes payable
Derivitive Treatment Date		Mar. 7, 2016
Maturity Date		Mar. 7, 2017
Principal Note Amount		$ 50,000
Original Derivitive Valuation		$ 87,538
Conversions
Mark to Market	$ 1,171
Derivative Value	$ 88,709
8% Convertible Notes Payable- issued March 7, 2016 [Member]
Summary of convertible notes payable
Derivitive Treatment Date		Mar. 7, 2016
Maturity Date		Jan. 7, 2017
Principal Note Amount		$ 46,803
Original Derivitive Valuation		$ 82,115
Conversions
Mark to Market	$ 1,101
Derivative Value	$ 83,216

Derivatives and Fair Value In41

Derivatives and Fair Value Instruments (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 07, 2016	Jan. 07, 2016	Jun. 25, 2015	Jun. 12, 2015
Derivatives and Fair Value Instruments (Textual)
Interest rate on convertible notes	20.00%	8.00%	8.00%
Derivative, description	An event of default for the Convertible Note would occur 0% of the time, increasing 1.00% per month to a maximum of 5.0%;- Alternative financing for the Convertible Note would be initially available to redeem the note 0% of the time and increase monthly by 1% to a maximum of 10%;
Monthly trading volume	$ 211,133
Description of embedded derivative	The monthly trading volume would average $211,113 and would increase at 5% per month;ownership limits conversion across LG's 6 notes based on 4.99% with shares outstanding increasing monthly by 1%.
Maximum [Member]
Derivatives and Fair Value Instruments (Textual)
Projected annual volatility	252.00%
Stock price	$ 0.010
Variable conversion rate	58.00%
Derivatives trading preiod	20 days
Derivatives effective rate	50.55%
Minimum [Member]
Derivatives and Fair Value Instruments (Textual)
Projected annual volatility	151.40%
Stock price	$ 0.0073
Variable conversion rate	50.00%
Derivatives trading preiod	3 days
Derivatives effective rate	36.13%
5% Convertible Note Payable-issued 6/12/15 [Member]
Derivatives and Fair Value Instruments (Textual)
Interest rate on convertible notes					5.00%
8% Convertible Note Payable-issued 6/25/15 [Member]
Derivatives and Fair Value Instruments (Textual)
Interest rate on convertible notes				8.00%

Stockholders' Equity (Details)

Stockholders' Equity (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2016	Dec. 31, 2015
Stockholders Equity (Textual)
Common stock, shares authorized	1,500,000,000	1,500,000,000
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares outstanding	41,588,879	35,101,750
Common stock, shares issued	41,588,879	35,101,750
Convertible preferred stock description	The Series B preferred stock has no voting rights. The holders of the Series B convertible preferred stock have the right to convert the same into Common Stock of the Corporation at the ratio of one (1) share of Series B Convertible Preferred for five hundred (500) shares of Common Stock.
Issuance of Series B preferred shares as payment for inventory	$ 50,000
Common Stock [Member]
Stockholders Equity (Textual)
Common stock, shares authorized	1,500,000,000	1,500,000,000
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares outstanding	41,588,879	35,101,750
Common stock, shares issued	41,588,879	35,101,750
Common stock issued for services		3,500,000
Issuance of Series B Preferred shares as part consideration for license agreement, Shares
Issuance of common shares upon conversion of shares	1,700,000
Issuance of Series B preferred shares as payment for inventory
Issuance of Series B preferred shares as payment for inventory, Shares
March 31, 2015 One [Member]
Stockholders Equity (Textual)
Common stock, par value	$ 0.001
Common stock, shares issued	2,000,000
March 31, 2015 Two [Member]
Stockholders Equity (Textual)
Common stock, par value	$ 0.0005
Common stock, shares issued	800,000
March 31, 2015 Three [Member]
Stockholders Equity (Textual)
Cancellation of common shares to recapitalize company (Shares)	500,000
June 30, 2015 [Member]
Stockholders Equity (Textual)
Common stock, par value	$ 0.0005
Common stock, shares issued	2,300,000
September 30, 2015 [Member]
Stockholders Equity (Textual)
Common stock, par value	$ 0.0005
Common stock, shares issued	3,800,000
September 30, 2015 One [Member]
Stockholders Equity (Textual)
Common stock, par value	$ 0.015
Common stock, shares issued	20,000
Percentage of aquisition	100.00%
September 30, 2015 Two [Member]
Stockholders Equity (Textual)
Common stock, par value	$ 0.01
Common stock, shares issued	500,000
Officers Compensation [Member]
Stockholders Equity (Textual)
Common stock, par value	$ 0.01
Common stock, shares issued	3,000,000
December 31, 2015 [Member]
Stockholders Equity (Textual)
Common stock, par value	$ 0.01
Common stock, shares issued	500,000
December 31, 2015 One [Member]
Stockholders Equity (Textual)
Common stock, par value	$ 0.01
Common stock, shares issued	200,000
March 31, 2016 Four [Member]
Stockholders Equity (Textual)
Common stock, par value	$ 0.00275
Common stock, shares issued	1,095,036
March 31, 2016 Five [Member]
Stockholders Equity (Textual)
Common stock, par value	$ 0.00275
Common stock, shares issued	1,285,560
March 31, 2016 Six [Member]
Stockholders Equity (Textual)
Common stock, par value	$ 0.003355
Common stock, shares issued	906,533
March 31, 2016 Seven [Member]
Stockholders Equity (Textual)
Common stock, par value	$ 0.00275
Common stock, shares issued	1,500,000
Series A preferred stock [Member]
Stockholders Equity (Textual)
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares issued	50,000	50,000
Preferred stock, shares outstanding	50,000	50,000
Common stock issued for services		100
Series B Preferred Stock [Member]
Stockholders Equity (Textual)
Common stock, shares issued	1,700,000
Preferred stock, shares authorized	50,000	50,000
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares issued	31,600	0
Preferred stock, shares outstanding	31,600	0
Issuance of Series B Preferred shares as part consideration for license agreement, Shares	25,000
Issuance of common shares upon conversion of shares	(3,400)
Issuance of Series B preferred shares as payment for inventory, Shares	10,000

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Commitments and contingencies (Texual)
Current office space rate per month	$ 1,725
Commitments description	The Company also has ready-to-go office space available at a nominal cost of approx. $100 per month with no commitment to be used for meetings etc.
Payments for rent	$ 346
Rent expense	2,071	$ 0
Stockholder [Member]
Commitments and contingencies (Texual)
Current office space rate per month	$ 525

Income Taxes (Details)

Income Taxes (Details)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Reconciliation of income tax rate [Abstract]
Statutory federal income tax rate	34.00%	34.00%
State income taxes, net of federal taxes	9.00%	9.00%
Valuation allowance	(43.00%)	(43.00%)
Effective income tax rate	0.00%	0.00%

Income Taxes (Details Textual)

Income Taxes (Details Textual)	3 Months Ended
	Mar. 31, 2016USD ($)
Income Taxes (Textual)
Net operating loss carryforward	$ 976,000
Operating loss carryforwards expiration period, description	Reduce future federal and state taxable income through 2035.

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Owed amount of related parties
Due to related party	$ 8,921	$ 8,921
Due to Officer/Stockholder	8,446	8,446
Due to other Stockholders	3,113	55,199
Total Related Party Obligations	$ 20,480	$ 72,566

Related Party Transactions (D47

Related Party Transactions (Details Textual) - USD ($)	1 Months Ended		3 Months Ended
	Sep. 30, 2015	Aug. 31, 2015	Mar. 31, 2016	Mar. 31, 2015	Feb. 29, 2016	Dec. 31, 2015	Dec. 13, 2015	Aug. 19, 2015	Dec. 13, 2014
Related Party Transaction [Line Items]
Fair value of acquired entity								$ 20
Impairment of Trademark	$ 20,000
Officer's compensation			$ 25,000	$ 25,000
Accounts payable and accrued expenses			$ 85,250			$ 123,648
Series B Preferred Stock
Related Party Transaction [Line Items]
Issuance of Series B Preferred shares as part consideration for license agreement, Shares			25,000
Issuance of common shares upon conversion of shares			3,400
Converted into shares of common stock			1,700,000
Settlement of liability			10,000
Promissory Note [Member]
Related Party Transaction [Line Items]
Promissory note issued by company			$ 150,000		$ 7,000
Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Base compensation							$ 100,000		$ 100,000
Officer's compensation			18,974	$ 30,000
President [Member]
Related Party Transaction [Line Items]
Accounts payable and accrued expenses			50,000			50,000
Medical Lasers Manufacturer, Inc. [Member]
Related Party Transaction [Line Items]
Percentage of aquisition		100.00%
Common stock shares issued for acquisition		20,000
Price per share		$ 0.015
Fair value of acquired entity		$ 20,000
Purchase of inventory		$ 50,000
Acquisition of MLM, description		MLM acquired a trademark from the son of the Company's President for $20,000 due 90 days from the date of acquisition.
Accounts payable and accrued expenses			$ 20,000			$ 20,000

Basis of Reporting - Going Co48

Basis of Reporting - Going Concern (Details)	3 Months Ended
	Mar. 31, 2016USD ($)
Basis of Reporting (Textual)
Net losses	$ 1,304,222

Subsequent Events (Details)

Subsequent Events (Details)

May. 05, 2016USD ($)shares

May. 04, 2016USD ($)shares

May. 02, 2016USD ($)

Apr. 15, 2016USD ($)Daysshares

Apr. 05, 2016USD ($)shares

Jan. 07, 2016USD ($)

Apr. 18, 2016shares

Jan. 31, 2016USD ($)

Mar. 31, 2016USD ($)

May. 11, 2016USD ($)shares

May. 10, 2016USD ($)shares

Dec. 31, 2015USD ($)

Mar. 07, 2016

Jan. 13, 2016USD ($)

Subsequent Event Textual [Abstract]

Issuance of common shares value

$ 20

Interest rate

8.00%

20.00%

8.00%

Remaining unassigned principal amount

$ 514,269

$ 441,803

Maturity date

Jan. 7, 2017

Jul. 2, 2012

Principal amount converted

$ 105,000

$ 251,803

Investor [Member]

Subsequent Event Textual [Abstract]

Remaining unassigned principal amount

$ 50,000

Consultant [Member]

Subsequent Event Textual [Abstract]

Issuance of common shares value

$ 500,000

Subsequent Event [Member]

Subsequent Event Textual [Abstract]

Issuance of common shares | shares

300,000

Remaining unassigned principal amount

$ 45,000

Principal amount converted

$ 2,800

$ 8,800

$ 3,000

$ 7,241

Convertible notes payable converted into common stock | shares

768,026

2,000,000

783,062

2,194,200

Pricipal balance due after conversion

$ 46,200

$ 26,200

$ 49,000

$ 52,759

Outstanding convertible note

$ 59,000

Subsequent Event [Member] | Series B Preferred Stock [Member]

Subsequent Event Textual [Abstract]

Issuance of common shares | shares

1,100,000

Convertible notes payable converted into common stock | shares

2,200

Subsequent Event [Member] | Investor [Member] | Redeemable Convertible Note [Member]

Subsequent Event Textual [Abstract]

Interest rate

8.00%

Remaining unassigned principal amount

$ 57,750

Maturity date

May 2, 2017

Debt discounted rate, percentage

10.00%

Description of conversion of convertible notes

The holder of the note is entitled, at its option beginning on the 6 month anniversary, to convert all or any of the principal face amount of the Note then outstanding into shares of the Company's common stock at the price equal to 55% of the lowest trading price for the twenty prior trading days including the date of conversion

Subsequent Event [Member] | Investor [Member] | Redeemable Convertible Note One [Member]

Subsequent Event Textual [Abstract]

Interest rate

8.00%

Remaining unassigned principal amount

$ 60,000

Maturity date

May 2, 2017

Description of conversion of convertible notes

This Replacement Note partially replaces a note originally issued on June 12, 2015 in the principal amount of $100,000 The holder of the note is entitled, at its option beginning on the 6 month anniversary, to convert all or any of the principal face amount of the Note then outstanding into shares of the Company's common stock at the price equal to 55% of the lowest trading price for the twenty prior trading days including the date of conversion

Subsequent Event [Member] | Consultant [Member]

Subsequent Event Textual [Abstract]

Business days | Days

125

Consultant fee

$ 750

Issuance of common shares | shares

500,000

Issuance of common shares value

$ 5,000